Fri, Apr 19, 2024 12:08 PM
TSMC's shares slide nearly 7% in Taipei on global chip outlook concerns
A Flip by Avya Verma
Ajanta Pharma on May 2 reported a 66 percent jump in consolidated net profit of Rs 202.72 crore for the Jan-March quarter of FY24, up from last year's Rs 122.25 crore.The Mumbai-based pharma major's revenue came in at Rs 1,054.08 crore, up 20 percent from Rs 881.84 crore a year back.The Board also made a decision on buyback of up to 10,28,881 fully paid-up Equity Shares.
Open Flip
Uber Technologies Inc. was sued by thousands of London’s black cab drivers in a suit seeking hundreds of million pounds accusing it of unlawfully operating in the capital city. The claim alleges Uber improperly obtained a license to operate in the city and made unlawful gains for at least six years from 2012, RGL Management Ltd., the firm running the claim, said.
Open Flip
The phrase "the golden age of biotech" was somewhat popular a few years ago but now seems largely forgotten. Regardless, biotech companies can be excellent long-term investment options for several reasons. Many are highly innovative corporations that develop breakthrough medicines for rare and hard-to-treat diseases. Even when they target more common conditions, some biotechs have deep lineups.
Open Flip
